Neurocrine Biosciences Inc is > 10% Shareholder of Voyager Therapeutics, Inc.. Currently has a direct ownership of 8.58 Million shares of VYGR, which is worth approximately $49.3 Million. The most recent transaction as insider was on Feb 23, 2023, when has been sold 4,395,588 shares (Common Stock) at a price of $8.88 per share, resulting in proceeds of $39,032,821. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.58M
0% 3M change
0% 12M change
Total Value Held $49.3 Million

NEUROCRINE BIOSCIENCES INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2023
BUY
Open market or private purchase
$39,032,821 $8.88 p/Share
4,395,588 Added 33.89%
8,575,316 Common Stock
NBI

Neurocrine Biosciences Inc

> 10% Shareholder
San Diego, CA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR